394 results on '"Crowley, Aaron"'
Search Results
2. The impact of different censoring methods for analyzing survival using real-world data with linked mortality information: a simulation study
3. Neutrophil‐to‐Lymphocyte Ratios in Patients Undergoing Aortic Valve Replacement: The PARTNER Trials and Registries
4. Real-World Characteristics of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: An Analysis of Electronic Healthcare Records in the United States
5. Abstract 12926: Characteristics of Tafamidis-Treated Patients With Mixed Phenotype Transthyretin Amyloidosis: A Real-World Study in the Medicare Fee-for-Service Population
6. Abstract 11748: A Retrospective Observational Study Exploring Real-World Diagnostic Workup of Patients With Wild-Type Transthyretin Amyloid Cardiomyopathy and/or Light Chain Amyloidosis
7. Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials
8. 2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques
9. Tafamidis medication adherence and persistence in patients with transthyretin amyloid cardiomyopathy in Japan
10. Social Determinants of Health-Related Disparities in the Diagnosis of Transthyretin Cardiac Amyloidosis
11. Crossing points in survival analysis sensitively depend on system conditions
12. How Cox models react to a study-specific confounder in a patient-level pooled dataset: Random-effects better cope with an imbalanced covariate across trials unless baseline hazards differ
13. Assimilated LVEF: A Bayesian technique combining human intuition with machine measurement for sharper estimates of left ventricular ejection fraction and stronger association with outcomes
14. Abstract 13699: Bivalirudin versus Heparin in Patients With NSTEMI Undergoing PCI: Individual-Patient-Data Pooled Analysis of the 5 Major Randomized Trials
15. Abstract 13639: Bivalirudin versus Heparin in Patients With STEMI Undergoing PCI: Individual-Patient-Data Pooled Analysis of the 6 Major Randomized Trials
16. A neural system dynamics modeling platform and its applications in randomized controlled trial data analysis
17. Outcomes After Left Main Coronary Artery Revascularization by Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting According to Smoking Status
18. Prognostic Impact of Race in Patients Undergoing PCI: Analysis From 10 Randomized Coronary Stent Trials
19. BMI, Infarct Size, and Clinical Outcomes Following Primary PCI: Patient-Level Analysis From 6 Randomized Trials
20. Comparison of Age (
21. Usefulness of Discharge Resting Heart Rate to Predict Adverse Cardiovascular Outcomes in Patients With Left Main Coronary Artery Disease Revascularized With Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting (from the EXCEL Trial)
22. 3-Year Outcomes After Valve-in-Valve Transcatheter Aortic Valve Replacement for Degenerated Bioprostheses: The PARTNER 2 Registry
23. Time-of-Day and Clinical Outcomes After Surgical or Transcatheter Aortic Valve Replacement: Insights From the PARTNER Trials
24. Impact of renin-angiotensin system inhibitors after revascularization of patients with left main coronary artery disease
25. Contemporary Outcomes Following Coronary Artery Bypass Graft Surgery for Left Main Disease
26. Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes
27. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Cardiac Surgery in the Randomized PARTNER 2A Trial
28. Outcomes of Patients with Significant Obesity Undergoing TAVR or SAVR in the Randomized PARTNER 2A Trial
29. Impact of Resting Heart Rate at 30 Days Following Transcatheter or Surgical Aortic Valve Replacement and Cardiovascular Outcomes: Insights from The PARTNER 2 Trial
30. Implications of Concomitant Tricuspid Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement for Degenerated Surgical Aortic Bioprosthesis: Insights From the PARTNER 2 Aortic Valve-in-Valve Registry
31. Prognostic significance of QRS fragmentation and correlation with infarct size in patients with anterior ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: Insights from the INFUSE-AMI trial
32. Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts
33. Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial
34. Does calcium burden impact culprit lesion morphology and clinical results? An ADAPT-DES IVUS substudy
35. CT-Defined Prosthesis–Patient Mismatch Downgrades Frequency and Severity, and Demonstrates No Association With Adverse Outcomes After Transcatheter Aortic Valve Replacement
36. Prosthetic Valve Endocarditis After TAVR and SAVR: Insights From the PARTNER Trials
37. Impact of Smoking on Platelet Reactivity and Clinical Outcomes After Percutaneous Coronary Intervention: Findings From the ADAPT-DES Study
38. Abstract 6754: Clinical characteristics, real-world treatment patterns, and clinical outcomes among patients with previously treated metastatic or unresectable EGFR-mutated non-small cell lung cancer in the United States
39. Clinical Characteristics Of Patients With Concurrent Calcific Aortic Stenosis And Transthyretin Cardiac Amyloidosis
40. Safety and Effectiveness of Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses: The Disrupt CAD II Study
41. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score: Analysis From the EXCEL Trial
42. Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials
43. TCT-435 Clinical Outcomes in Patients With Concurrent Calcific Aortic Stenosis and Transthyretin Cardiac Amyloidosis
44. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial
45. Cardiovascular and Noncardiovascular Death After Percutaneous Coronary Intervention: Insights From 32 882 Patients Enrolled in 21 Randomized Trials
46. Evaluation of left ventricular reverse remodeling in patients with severe aortic regurgitation undergoing aortic valve replacement: Comparison between diameters and volumes
47. CHARACTERISTICS OF PATIENTS WITH WILD-TYPE TRANSTHYRETIN CARDIAC AMYLOIDOSIS PRESCRIBED TAFAMIDIS - A REAL-WORLD DESCRIPTIVE ANALYSIS USING ELECTRONIC HEALTH RECORDS
48. Paravalvular regurgitation after transcatheter aortic valve replacement in intermediate-risk patients: a pooled PARTNER 2 study
49. Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial
50. Optimal dual antiplatelet therapy duration for bioresorbable scaffolds: an individual patient data pooled analysis of the ABSORB trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.